Literature DB >> 17080094

Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures.

M Cohen-Wolkowiez1, P B Smith, B Mangum, W J Steinbach, B D Alexander, C M Cotten, R H Clark, T J Walsh, D K Benjamin.   

Abstract

OBJECTIVE: The purpose of this study was to examine the frequency of normal cerebrospinal fluid (CSF) parameters in Candida meningitis and the proportion of candidemia associated with Candida meningitis. STUDY
DESIGN: We evaluated the initial lumbar puncture results from infants discharged from 150 Neonatal Intensive Care Units between 1997 and 2004. Candida meningitis was diagnosed by a positive CSF culture or positive Gram stain for yeast. We calculated two-tailed P-values using non-parametric testing, Mann-Whitney, Kruskal-Wallis or Fisher's exact tests where appropriate.
RESULTS: Twenty infants had culture-positive Candida meningitis. Normal CSF parameters were found in 43% (3/7) of the infants with Candida meningitis and only 37% (7/19) of them had positive blood cultures for Candida.
CONCLUSION: Normal CSF parameters do not exclude the diagnosis of neonatal Candida meningitis. The majority of infants in this cohort with Candida meningitis did not have evidence of candidemia at the time of diagnosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17080094     DOI: 10.1038/sj.jp.7211628

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  14 in total

Review 1.  Safety of micafungin in infants: insights into optimal dosing.

Authors:  Simon Ascher; Phillip Brian Smith; Daniel K Benjamin
Journal:  Expert Opin Drug Saf       Date:  2011-01-13       Impact factor: 4.250

Review 2.  Neonatal candidiasis: diagnosis, prevention, and treatment.

Authors:  Rachel G Greenberg; Daniel K Benjamin
Journal:  J Infect       Date:  2014-08-13       Impact factor: 6.072

Review 3.  Neonatal fungal infections: when to treat?

Authors:  E Hsieh; P B Smith; E Jacqz-Aigrain; F Kaguelidou; M Cohen-Wolkowiez; P Manzoni; D K Benjamin
Journal:  Early Hum Dev       Date:  2012-05       Impact factor: 2.079

4.  Fatal immune reconstitution inflammatory syndrome with human immunodeficiency virus infection and Candida meningitis: case report and review of the literature.

Authors:  Jennifer L Berkeley; Avindra Nath; Carlos A Pardo
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

5.  Group B streptococcal meningitis: cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis.

Authors:  Annette K Ansong; P Brian Smith; Daniel K Benjamin; Reese H Clark; Jennifer S Li; C Michael Cotten; Barry Mangum; Harmony P Garges; Daniel K Benjamin
Journal:  Early Hum Dev       Date:  2009-09-19       Impact factor: 2.079

6.  [Use of lumbar puncture in the evaluation of late-onset sepsis in low birth weight neonates].

Authors:  Alonso Zea-Vera; Christie Gloria Turín; María Susana Rueda; Daniel Guillén-Pinto; Pilar Medina-Alva; Aldredo Tori; María Rivas; Jaime Zegarra; Anne Castañeda; Luis Cam; Theresa J Ochoa
Journal:  Rev Peru Med Exp Salud Publica       Date:  2016-06

7.  (1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients.

Authors:  Christine M Salvatore; Tempe K Chen; Sima S Toussi; Patricia DeLaMora; Ruta Petraitiene; Malcolm A Finkelman; Thomas J Walsh
Journal:  J Pediatric Infect Dis Soc       Date:  2015-03-19       Impact factor: 3.164

8.  The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates.

Authors:  William W Hope; Diana Mickiene; Vidmantas Petraitis; Ruta Petraitiene; Amy M Kelaher; Joanna E Hughes; Margaret P Cotton; John Bacher; James J Keirns; Donald Buell; Gloria Heresi; Daniel K Benjamin; Andreas H Groll; George L Drusano; Thomas J Walsh
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

9.  Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.

Authors:  Ruta Petraitiene; Vidmantas Petraitis; William W Hope; Diana Mickiene; Amy M Kelaher; Heidi A Murray; Christine Mya-San; Johanna E Hughes; Margaret P Cotton; John Bacher; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2008-09-08       Impact factor: 5.191

10.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.